Inventor · disambiguated record
Thomas Helleday
Also filed as: HELLEDAY THOMAS
15 granted patents·7 pending applications·86 citations·filing 2004–2024
89Inventor score
Files withTHOMAS HELLEDAYS STIFTELSE FOER MEDICINSK FORSKNING6THOMAS HELLEDAYS STIFTELSE FOR MEDICINSK FORSKNING6UNIV SHEFFIELD4CANCER REC TECH LTD2VERTEX PHARMA2
Top patents by PatentIndex Score
22 records- 0192US7351701B2Therapeutic compoundsCANCER REC TECH LTD·Filed 2004·Granted Apr 1, 2008·50 cites·6 claims
- 0284US7531530B2Therapeutic compoundsCANCER REC TECH LTD·Filed 2004·Granted May 12, 2009·19 cites·15 claims
- 0375US2022062286A1Use of rnai inhibiting parp activity for the manufacture of a medicament for the treatment of cancerUNIV SHEFFIELD·Filed 2021·Application pending·0 cites
- 0475US2020237762A1Use of rnai inhibiting parp activity for the manufacture of a medicament for the treatment of cancerUNIV SHEFFIELD·Filed 2019·Application pending·0 cites
- 0574US9604937B2Pyrimidine-2,4-diamine derivatives for treatment of cancerTHOMAS HELLEDAYS STIFTELSE FOR MEDICINSK FORSKNING·Filed 2013·Granted Mar 28, 2017·3 cites·11 claims
- 0674US8859562B2Use of RNAI inhibiting PARP activity for the manufacture of a medicament for the treatment of cancerHELLEDAY THOMAS·Filed 2004·Granted Oct 14, 2014·8 cites·1 claims
- 0773US10064869B2MTH1 inhibitors for treatment of inflammatory and autoimmune conditionsTHOMAS HELLEDAYS STIFTELSE FOR MEDICINSK FORSKNING·Filed 2015·Granted Sep 4, 2018·3 cites·29 claims
- 0870US10632125B2MTH1 inhibitors for treatment of inflammatory and autoimmune conditionsTHOMAS HELLEDAYS STIFTELSE FOER MEDICINSK FORSKNING·Filed 2018·Granted Apr 28, 2020·1 cites·23 claims
- 0967US9944640B2Pyrimidine-2,4-diamine derivatives for treatment of cancerTHOMAS HELLEDAYS STIFTELSE FOR MEDICINSK FORSKNING·Filed 2017·Granted Apr 17, 2018·1 cites·25 claims
- 1066US12338226B2Substituted benzodiazoles and use thereof in therapyTHOMAS HELLEDAYS STIFTELSE FOER MEDICINSK FORSKNING·Filed 2024·Granted Jun 24, 2025·0 cites·20 claims
- 1166US11179394B2Method for treating cancer using a combination of Chk1 and ATR inhibitorsVERTEX PHARMA·Filed 2015·Granted Nov 23, 2021·1 cites·17 claims
- 1263US12357634B22,6-diamino-3,4-dihydropyrimidin-4-one derivatives and use thereof in therapyTHOMAS HELLEDAYS STIFTELSE FOER MEDICINSK FORSKNING·Filed 2022·Granted Jul 15, 2025·0 cites·15 claims
- 1362US2015005327A1Use of RNAI Inhibiting PARP Activity for the Manufacture of a Medicament for the Treatment of CancerUNIV SHEFFIELD·Filed 2014·Application pending·0 cites
- 1459US2018000822A1Use of RNAI Inhibiting PARP Activity for the Manufacture of a Medicament for the Treatment of CancerUNIV SHEFFIELD·Filed 2017·Application pending·0 cites
- 1557US2022249489A1Method for treating cancer using a combination of chk1 and atr inhibitorsVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 1652US10174029B2Pyrimidine-2,4-diamine derivatives for treatment of cancerTHOMAS HELLEDAYS STIFTELSE FOR MEDICINSK FORSKNING·Filed 2018·Granted Jan 8, 2019·0 cites·20 claims
- 1751US11970474B2Substituted benzodiazoles and use thereof in therapyTHOMAS HELLEDAYS STIFTELSE FOER MEDICINSK FORSKNING·Filed 2019·Granted Apr 30, 2024·0 cites·17 claims
- 1846US11504368B22,6-diamino-3,4-dihydropyrimidin-4-one derivatives and use thereof in therapyTHOMAS HELLEDAYS STIFTELSE FOER MEDICINSK FORSKNING·Filed 2019·Granted Nov 22, 2022·0 cites·15 claims
- 1934US2021128566A1Novel functionalized purine-2,6-diones and their use in medicineTHOMAS HELLEDAYS STIFTELSE FOER MEDICINSK FORSKNING·Filed 2018·Application pending·0 cites
- 2033US2017305893A1Heterocyclic compounds as dctpp1 modulatorsTHOMAS HELLEDAYS STIFTELSE FOR MEDICINSK FORSKNING·Filed 2015·Application pending·0 cites
- 2129US10179790B2MTH1 inhibitors for treatment of cancerTHOMAS HELLEDAYS STIFTELSE FOR MEDICINSK FORSKNING·Filed 2015·Granted Jan 15, 2019·0 cites·46 claims
- 2227US10000449B2Bisarylsulfonamides useful in the treatment of inflammation and cancerKANCERA AB·Filed 2016·Granted Jun 19, 2018·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Thomas Helleday files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →